Chugai Pharmaceutical Co Ltd 2024 IR
The report highlights Chugai Pharmaceutical's financial and non-financial performance for the fiscal year ended December 31, 2024, marking its 100th anniversary. The company achieved record-high Core revenue exceeding ¥1.17 trillion and Core operating profit of over ¥556 billion. Key achievements include the global launch of its fifth in-house product, PiaSky, and the approval of NEMLUVIO in the United States. Chugai also revised its materiality framework into 16 material issues across three axes: Challenges, Co-creation, and Commitments. Additionally, the company made significant progress toward its Mid-Term Environmental Goals 2030, reducing Scope 1 and 2 emissions by 52.2% compared to 2019.
Company: Chugai Pharmaceutical Co Ltd
Sector: Health Care
Country: Japan
Year: 2024
Type: IR
Pages: 96
Chugai Pharmaceutical Co Ltd
Annual Report
The report highlights Chugai Pharmaceutical's financial and non-financial performance for the fiscal year ended December 31, 2024, marking its 100th anniversary. The company achieved record-high Core revenue exceeding ¥1.17 trillion and Core operating profit of over ¥556 billion. Key achievements include the global launch of its fifth in-house product, PiaSky, and the approval of NEMLUVIO in the United States. Chugai also revised its materiality framework into 16 material issues across three axes: Challenges, Co-creation, and Commitments. Additionally, the company made significant progress toward its Mid-Term Environmental Goals 2030, reducing Scope 1 and 2 emissions by 52.2% compared to 2019.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2024
Reporting Period
Jan 1, 2024 - Dec 31, 2024
Fiscal Year
2024
Type
Integrated Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Women in Management
Net Zero Target
Employees